Prior work has shown that primary atypical meningiomas, comprised mostly of NF2 mutants with genomic instability or recurrent SMARCB1 mutations, display a hypermethylated phenotype due to increased polycomb repressive complex 2 (PRC2) activity (13). The gene discussed is NF2; the disease is meningioma.